Clinical Trial Update: Study of Bitopertin in Participants With EPP or XLP (APOLLO) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of bitopertin (APOLLO) in participants with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) is active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria
• X-linked Protoporphyria

Drugs mentioned

• Bitopertin (bitopertin)

Snippet

Sponsor: Disc Medicine, Inc | Conditions: Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP) | Phase 3 | Status: ACTIVE_NOT_RECRUITING